Q: What is Votrient used for?

Votrient is used to treat renal cell carcinoma and soft tissue sarcoma .

Q: How does Votrient work?

Mechanism of Action Votrient belongs to a class of medications called kinase inhibitors. It works by interfering with the signals that tell cancer cells to grow and multiply. The medication targets several specific proteins, known as tyrosine kinases, which are found on the surface of both healthy and cancerous cells. In some cancers, these proteins are overactive, leading to uncontrolled cell growth. Votrient helps block these signals to slow or stop the progression of the disease. Inhibiting Tumor Growth Votrient works in two main ways to combat cancer: Blocking cell division: By inhibiting specific growth factor receptors, the drug prevents cancer cells from receiving the signals they need to divide and spread. Stopping angiogenesis: Tumors require a dedicated blood supply to grow. Votrient blocks the vascular endothelial growth factor (VEGF) pathway, which prevents the tumor from forming new blood vessels. Without an adequate blood supply, the tumor cannot get the oxygen and nutrients it needs to survive and expand. Because Votrient targets specific proteins involved in cell signaling, it is considered a targeted therapy. It is primarily used to treat advanced stages of certain cancers, such as renal cell carcinoma (kidney cancer) and soft tissue sarcoma.

Q: What are the active ingredients in Votrient?

The active ingredient in Votrient is pazopanib .

Q: What are the side effects of Votrient?

Common side effects of Votrient may include: diarrhea high blood pressure fatigue and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Votrient?

Votrient belongs to the tyrosine kinase inhibitor drug class.

Q: What is the dosage of Votrient and how do I take it?

How to Take Votrient Votrient is a tablet taken by mouth. It is usually taken once a day. To ensure the medication works correctly, follow these administration guidelines: Timing: Take your dose at the same time each day to maintain a consistent level of medicine in your body. Food: Take Votrient on an empty stomach, which means at least one hour before or two hours after eating a meal. Taking this medication with food can significantly change how much of the drug your body absorbs. Swallowing: Swallow the tablets whole with a glass of water. Do not crush, chew, or break the tablets, as this can cause the body to absorb the medication too quickly. Dietary Restrictions: Avoid drinking grapefruit juice or eating grapefruit while taking this medication, as it may interfere with how the drug is processed. Missed Dose If you miss a dose, take it as soon as you remember. However, if your next scheduled dose is due in less than 12 hours, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

Q: Is Votrient safe during pregnancy and breastfeeding?

Pregnancy Votrient can cause fetal harm when administered to a pregnant woman. Based on animal studies and its mechanism of action, this medication may lead to birth defects or pregnancy loss. It is important to inform a healthcare provider if you are pregnant or planning to become pregnant before starting this treatment. Healthcare providers typically recommend the following precautions regarding pregnancy: Pregnancy Testing: Females of reproductive potential should have a pregnancy test to confirm they are not pregnant before starting Votrient. Contraception for Females: Use effective birth control during treatment and for at least 2 weeks after the final dose. Contraception for Males: Men with female partners who can become pregnant should use effective contraception during treatment and for at least 2 weeks after the final dose. Breastfeeding It is not known whether Votrient passes into human breast milk. Due to the risk of serious side effects in a nursing infant, breastfeeding is not recommended during treatment with Votrient and for at least 2 weeks after the last dose.

Q: What is the FDA approval status of Votrient?

FDA Approval History Votrient (pazopanib) was first approved by the U.S. Food and Drug Administration (FDA) in October 2009. Its initial approval was for the treatment of patients with advanced renal cell carcinoma, which is a form of kidney cancer. In April 2012, the FDA expanded the approved use of Votrient to include the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy. The FDA noted that the drug's effectiveness has not been established for patients with adipocytic soft tissue sarcoma or gastrointestinal stromal tumors. Boxed Warning The FDA has issued a Boxed Warning for Votrient, which is the most serious type of warning required for prescription medications. This warning is due to the risk of hepatotoxicity, or severe liver injury, which can be fatal. Because of this risk, the FDA requires healthcare providers to perform liver function tests before starting the medication and to continue monitoring liver health throughout the course of treatment. Regulatory Status and Monitoring Votrient is a prescription-only medication. In addition to liver monitoring, the FDA-approved labeling includes warnings regarding other serious risks that require clinical oversight, such as: High blood pressure (hypertension) Heart rhythm changes (QT prolongation) Heart failure or decreased heart pumping function Severe bleeding events Perforations or tears in the stomach or intestines Thyroid dysfunction Regulatory authorities continue to monitor the safety of Votrient through post-marketing surveillance and clinical trials investigating its use in different patient populations, including pediatric bone cancer research.

Question 1

What is Votrient?

Accepted Answer

Votrient is a targeted therapy medication classified as a kinase inhibitor. It works by blocking the activity of specific proteins that signal cancer cells to multiply and form new blood vessels.

By interfering with these signaling pathways, the medication helps to slow or stop the growth of certain tumors. This process limits the ability of cancer cells to survive and expand within the body.

Question 2

What is Votrient used for?

Accepted Answer

Votrient is used to treat renal cell carcinoma and soft tissue sarcoma.

Question 3

How does Votrient work?

Accepted Answer

Mechanism of Action

Votrient belongs to a class of medications called kinase inhibitors. It works by interfering with the signals that tell cancer cells to grow and multiply.

The medication targets several specific proteins, known as tyrosine kinases, which are found on the surface of both healthy and cancerous cells. In some cancers, these proteins are overactive, leading to uncontrolled cell growth. Votrient helps block these signals to slow or stop the progression of the disease.

Inhibiting Tumor Growth

Votrient works in two main ways to combat cancer:

Blocking cell division: By inhibiting specific growth factor receptors, the drug prevents cancer cells from receiving the signals they need to divide and spread.
Stopping angiogenesis: Tumors require a dedicated blood supply to grow. Votrient blocks the vascular endothelial growth factor (VEGF) pathway, which prevents the tumor from forming new blood vessels. Without an adequate blood supply, the tumor cannot get the oxygen and nutrients it needs to survive and expand.

Because Votrient targets specific proteins involved in cell signaling, it is considered a targeted therapy. It is primarily used to treat advanced stages of certain cancers, such as renal cell carcinoma (kidney cancer) and soft tissue sarcoma.

Question 4

What are the active ingredients in Votrient?

Accepted Answer

The active ingredient in Votrient is pazopanib.

Question 5

What are the side effects of Votrient?

Accepted Answer

Common side effects of Votrient may include:

diarrhea
high blood pressure
fatigue
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Votrient?

Accepted Answer

Votrient belongs to the tyrosine kinase inhibitor drug class.

Question 7

What is the dosage of Votrient and how do I take it?

Accepted Answer

How to Take Votrient

Votrient is a tablet taken by mouth. It is usually taken once a day. To ensure the medication works correctly, follow these administration guidelines:

Timing: Take your dose at the same time each day to maintain a consistent level of medicine in your body.
Food: Take Votrient on an empty stomach, which means at least one hour before or two hours after eating a meal. Taking this medication with food can significantly change how much of the drug your body absorbs.
Swallowing: Swallow the tablets whole with a glass of water. Do not crush, chew, or break the tablets, as this can cause the body to absorb the medication too quickly.
Dietary Restrictions: Avoid drinking grapefruit juice or eating grapefruit while taking this medication, as it may interfere with how the drug is processed.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if your next scheduled dose is due in less than 12 hours, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

Question 8

Is Votrient safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Votrient can cause fetal harm when administered to a pregnant woman. Based on animal studies and its mechanism of action, this medication may lead to birth defects or pregnancy loss. It is important to inform a healthcare provider if you are pregnant or planning to become pregnant before starting this treatment.

Healthcare providers typically recommend the following precautions regarding pregnancy:

Pregnancy Testing: Females of reproductive potential should have a pregnancy test to confirm they are not pregnant before starting Votrient.
Contraception for Females: Use effective birth control during treatment and for at least 2 weeks after the final dose.
Contraception for Males: Men with female partners who can become pregnant should use effective contraception during treatment and for at least 2 weeks after the final dose.

Breastfeeding

It is not known whether Votrient passes into human breast milk. Due to the risk of serious side effects in a nursing infant, breastfeeding is not recommended during treatment with Votrient and for at least 2 weeks after the last dose.

Question 9

What forms and strengths does Votrient come in?

Accepted Answer

Votrient is supplied as a film-coated tablet intended for oral administration. The medication is designed to be swallowed whole and should not be crushed or broken.

Oral Tablet: A film-coated tablet taken by mouth.

Question 10

What is the FDA approval status of Votrient?

Accepted Answer

FDA Approval History

Votrient (pazopanib) was first approved by the U.S. Food and Drug Administration (FDA) in October 2009. Its initial approval was for the treatment of patients with advanced renal cell carcinoma, which is a form of kidney cancer.

In April 2012, the FDA expanded the approved use of Votrient to include the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy. The FDA noted that the drug's effectiveness has not been established for patients with adipocytic soft tissue sarcoma or gastrointestinal stromal tumors.

Boxed Warning

The FDA has issued a Boxed Warning for Votrient, which is the most serious type of warning required for prescription medications. This warning is due to the risk of hepatotoxicity, or severe liver injury, which can be fatal. Because of this risk, the FDA requires healthcare providers to perform liver function tests before starting the medication and to continue monitoring liver health throughout the course of treatment.

Regulatory Status and Monitoring

Votrient is a prescription-only medication. In addition to liver monitoring, the FDA-approved labeling includes warnings regarding other serious risks that require clinical oversight, such as:

High blood pressure (hypertension)
Heart rhythm changes (QT prolongation)
Heart failure or decreased heart pumping function
Severe bleeding events
Perforations or tears in the stomach or intestines
Thyroid dysfunction

Regulatory authorities continue to monitor the safety of Votrient through post-marketing surveillance and clinical trials investigating its use in different patient populations, including pediatric bone cancer research.

Question 11

What should I know about Votrient and cost?

Accepted Answer

Several factors can influence the total price of Votrient treatment:

Insurance Coverage: Your out-of-pocket expenses, such as copays or coinsurance, are determined by your specific health insurance plan. Some insurance providers may require prior authorization before they agree to cover the cost of the medication.
Pharmacy Choice: Prices may differ between local retail pharmacies, mail-order pharmacies, and specialty pharmacies.
Generic Availability: Pazopanib is the generic version of Votrient. Generic medications are generally less expensive than brand-name versions while providing the same therapeutic effect.

If you have difficulty affording Votrient, there may be resources available to help manage the cost:

Patient Assistance Programs: Drug manufacturers sometimes offer programs to provide medications at a lower cost or for free to individuals who meet specific financial criteria or lack insurance.
Copay Savings Cards: Patients with commercial insurance may be eligible for savings cards that reduce the amount paid at the pharmacy.

To understand your specific costs, it is best to contact your insurance provider or speak with your pharmacist. They can provide information on your plan's formulary and any available financial support options.

Votrient

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Votrient

Hospitals.net Disclosure